BC
TEVA icon

Barnett & Company’s Teva Pharmaceutical Industries Limited TEVA Stock Holding History

Barnett & Company’s Portfolio TEVA Stock Details TEVA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q3 		– Sell
-100
Closed -$3K – 353
2017
Q2 		$3K Hold
100
– – ﹤0.01% 343
2017
Q1 		$3K Hold
100
– – ﹤0.01% 324
2016
Q4 		$4K Sell
100
-380
-79% -$15.2K ﹤0.01% 354
2016
Q3 		$22K Hold
480
– – 0.01% 271
2016
Q2 		$24K Hold
480
– – 0.01% 259
2016
Q1 		$26K Buy
+480
New +$28.2K 0.01% 261

Other funds holding TEVA

Franklin Resources
Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $580B AUM 38.23% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
HCM
Highfields Capital Management Boston, Massachusetts $68.3M AUM 21.64% 1-Year Est. Return
NC
Northern Cross Boston, Massachusetts $279M AUM 1.98% 1-Year Est. Return
ACM
Abrams Capital Management Boston, Massachusetts $5.48B AUM 3.63% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
AllianceBernstein
AllianceBernstein Nashville, Tennessee $302B AUM 26.44% 1-Year Est. Return

Barnett & Company's TEVA Position: Q3 2017 in Review

Barnett & Company sold out of Teva Pharmaceutical Industries Limited (TEVA) in Q3 2017, closing a stake of 100 shares — an estimated $3K sold.

Barnett & Company first reported a position in TEVA in Q1 2016 and held it in 6 quarters. The position peaked at $26K in Q1 2016. 537 funds tracked by Wall St. Rank hold TEVA as of Q3 2017.

  • Barnett & Company reported no remaining Teva Pharmaceutical Industries Limited position as of Q3 2017 after selling out during the quarter.
  • Barnett & Company sold 100 Teva Pharmaceutical Industries Limited shares in Q3 2017, an estimated $3K.
  • Barnett & Company first reported a position in Teva Pharmaceutical Industries Limited in Q1 2016 and held it in 6 quarters.
  • Barnett & Company's Teva Pharmaceutical Industries Limited position peaked at $26K in Q1 2016.
  • 537 funds tracked by Wall St. Rank held Teva Pharmaceutical Industries Limited as of Q3 2017.

Based on Barnett & Company's 13F filing for Q3 2017, filed 20 Nov 2017.